{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:56:59Z","timestamp":1774619819550,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is currently the biggest public health problem worldwide. Intensive international travel and tourism have greatly contributed to its rapid global spreading. This study is the first comprehensive analysis of the epidemiological characteristics and clinical outcomes of the travel-associated COVID-19 cases in Vojvodina, Serbia, from March 6 to December 31, 2020 and it concerns permanent residents of Serbia. A cross-sectional study was conducted using data from the dedicated surveillance database of the Institute of Public Health of Vojvodina. Overall, 650 travel-associated COVID-19 cases were recorded in Vojvodina during the observed period, mainly imported from Bosnia and Herzegovina, followed by Austria and Germany (N = 195, 30%; N = 79, 12.15% and N = 75, 11.54%, respectively). The majority of cases were in the working-age groups, 18\u201344 and 45\u201364 years (56.46% and 34.15%, respectively). Overall, 54 (8.31%) patients developed pneumonia. In comparison to patients without pneumonia, those with pneumonia were older (mean age = 55.39 years vs. 41.34 years, <jats:italic>p<\/jats:italic>&lt;0.01) and had a higher percentage of comorbidities (57.41% vs. 16.61%). Men were more likely to develop pneumonia than women (OR = 2.22; 95% CI: 1.14\u20134.30, <jats:italic>p<\/jats:italic> = 0.02), as well as those in retired-age group (OR = 4.11; 95% CI: 2.0\u20138.46, p&lt;0.01). Obesity (OR = 14.40; 95% CI: 3.8\u201354.6, <jats:italic>p<\/jats:italic>&lt;0.01), diabetes (OR = 9.82; 95% CI: 3.15\u201330.61, <jats:italic>p<\/jats:italic>&lt;0.01) and hypertension (OR = 7.99; 95% CI: 3.98\u201316.02, <jats:italic>p<\/jats:italic>&lt;0.01) were the most prominent main comorbidities as predictors of pneumonia. Our results represent general epidemiological and clinical dynamics of COVID-19 disease in Vojvodina. Also, they provide evidence that the predictors of pneumonia were: increasing age, male sex, having underlying comorbidities, an increasing number of days from the return to laboratory confirmation of COVID-19 (OR = 1.08, 95% CI: 1.03\u20131.12, <jats:italic>p<\/jats:italic>&lt;0.01), as well as an increasing number of days from symptoms onset to diagnosis (OR = 1.14, 95% CI: 1.07\u20131.21, <jats:italic>p<\/jats:italic>&lt;0.01), while anosmia and ageusia were protective factors for developing it (OR = 0.31, 95% CI: 0.12\u20130.79, <jats:italic>p<\/jats:italic> = 0.01).<\/jats:p>","DOI":"10.1371\/journal.pone.0261840","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:48:59Z","timestamp":1640285339000},"page":"e0261840","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epidemiological characteristics of COVID-19 travel-associated cases in Vojvodina, Serbia, during 2020"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-6709","authenticated-orcid":true,"given":"Tatjana","family":"Pustahija","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mioljub","family":"Risti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5778-9861","authenticated-orcid":true,"given":"Sne\u017eana","family":"Medi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-7825","authenticated-orcid":true,"given":"Vladimir","family":"Vukovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"\u0160trbac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smiljana","family":"Raj\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7068-2882","authenticated-orcid":true,"given":"Aleksandra","family":"Pati\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"pone.0261840.ref001","unstructured":"Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). [cited 2021 April 1]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html"},{"issue":"1","key":"pone.0261840.ref002","doi-asserted-by":"crossref","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","article-title":"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.","volume":"98","author":"E Ortiz-Prado","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pone.0261840.ref003","unstructured":"World Health Organization. Estimating mortality from COVID-19. [cited 2021 April 6]. Available from: https:\/\/www.who.int\/news-room\/commentaries\/detail\/estimating-mortality-from-covid-19"},{"key":"pone.0261840.ref004","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. [cited 2021 June 12].Available from: https:\/\/covid19.who.int\/"},{"issue":"1","key":"pone.0261840.ref005","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2468-2667(20)30263-2","article-title":"Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study","volume":"6","author":"TW Russell","year":"2021","journal-title":"Lancet Public Health"},{"key":"pone.0261840.ref006","unstructured":"Ministry of Health of the Republic of Serbia. Coronavirus COVID-19. [cited 2021 June 12]. Available from: https:\/\/covid19.rs\/eng-coronavirus-analytics\/"},{"key":"pone.0261840.ref007","unstructured":"The Government of the Republic of Serbia. COVID-19. [cited 2021 June 12]. Available from: http:\/\/www.pravno-informacioni-sistem.rs\/fp\/covid19"},{"key":"pone.0261840.ref008","volume-title":"Liferiver Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit.","author":"Bio-Tech Corp, Ltd","year":"2020"},{"key":"pone.0261840.ref009","volume-title":"GeneFinder COVID-19 Plus RealAmp Kit\u2014Instructions for Use","author":"OSANG Healthcare Corp, Ltd"},{"key":"pone.0261840.ref010","volume-title":"ARGENE\u00ae SARS-COV-2 R-GENE.","author":"BioM\u00e9rieux, Inc","year":"2020"},{"key":"pone.0261840.ref011","volume-title":"Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2\u2014Instructions for Use.","author":"BGI Genomics Corp Ltd","year":"2021"},{"issue":"2","key":"pone.0261840.ref012","doi-asserted-by":"crossref","first-page":"e0247606","DOI":"10.1371\/journal.pone.0247606","article-title":"Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia.","volume":"16","author":"M Risti\u0107","year":"2021","journal-title":"PLoS ONE"},{"key":"pone.0261840.ref013","unstructured":"World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance. 11 September 2020. Geneva; 2020. [cited 2021 February 16]. Available from: https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays"},{"key":"pone.0261840.ref014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijid.2020.06.031","article-title":"Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.","volume":"97","author":"CY Lin","year":"2020","journal-title":"Int J Infect Dis"},{"key":"pone.0261840.ref015","article-title":"Early spread of COVID-19 in Romania: imported cases from Italy and human-to-human transmission networks.","author":"MG H\u00e2ncean","year":"2020","journal-title":"R Soc Open Sci"},{"key":"pone.0261840.ref016","doi-asserted-by":"crossref","first-page":"101653","DOI":"10.1016\/j.tmaid.2020.101653","article-title":"Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.","volume":"35","author":"JP Escalera-Antezana","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"8","key":"pone.0261840.ref017","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S1473-3099(20)30314-5","article-title":"Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series","volume":"20","author":"MM B\u00f6hmer","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"pone.0261840.ref018","doi-asserted-by":"crossref","first-page":"2001624","DOI":"10.2807\/1560-7917.ES.2020.25.42.2001624","article-title":"A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020.","volume":"25","author":"N Murphy","year":"2020","journal-title":"Euro Surveill"},{"issue":"7","key":"pone.0261840.ref019","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan","volume":"180","author":"C Wu","year":"2020","journal-title":"China. JAMA Intern Med"},{"key":"pone.0261840.ref020","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention.","volume":"323","author":"Z Wu","year":"2020","journal-title":"JAMA"},{"key":"pone.0261840.ref021","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019\u2014United States, February 12-March 28, 2020.","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0261840.ref022","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"CM Petrilli","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"pone.0261840.ref023","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajic.2020.06.213","article-title":"Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.","volume":"49","author":"KT Bajgain","year":"2021","journal-title":"Am J Infect Control"},{"key":"pone.0261840.ref024","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"W Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0261840.ref025","doi-asserted-by":"crossref","first-page":"102051","DOI":"10.1016\/j.tmaid.2021.102051","article-title":"Coronavirus disease 2019 pandemic in Greece, February 26\u2014May 3, 2020: The first wave.","volume":"41","author":"HC Maltezou","year":"2021","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"pone.0261840.ref026","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1080\/22221751.2020.1787103","article-title":"Epidemiology and clinical course of COVID-19 in Shanghai, China.","volume":"9","author":"Y Shen","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"15","key":"pone.0261840.ref027","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/cid\/ciaa199","article-title":"Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.","volume":"71","author":"J Wu","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pone.0261840.ref028","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.3390\/ijerph17093311","article-title":"Analysis of Imported Cases of COVID-19 in Taiwan: A Nationwide Study.","volume":"17","author":"JY Liu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0261840.ref029","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijid.2020.03.020","article-title":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).","volume":"94","author":"H Nishiura","year":"2020","journal-title":"Int J Infect Dis"},{"key":"pone.0261840.ref030","first-page":"1168","article-title":"The gendered dimensions of COVID-19","volume":"395","author":"The Lancet","year":"2020","journal-title":"Lancet"},{"key":"pone.0261840.ref031","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(20)30526-2","article-title":"COVID-19: the gendered impacts of the outbreak","volume":"395","author":"C Wenham","year":"2020","journal-title":"Lancet"},{"key":"pone.0261840.ref032","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.","volume":"8","author":"JM Jin","year":"2020","journal-title":"Front Public Health"},{"key":"pone.0261840.ref033","doi-asserted-by":"crossref","first-page":"980","DOI":"10.17269\/s41997-020-00417-z","article-title":"Sex, gender and COVID-19: a call to action","volume":"111","author":"S.B. Ahmed","year":"2020","journal-title":"Can J Public Health"},{"issue":"1","key":"pone.0261840.ref034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13293-020-00330-7","article-title":"Sex differences in severity and mortality from COVID-19: are males more vulnerable?","volume":"11","author":"A Pradhan","year":"2020","journal-title":"Biol Sex Differ"},{"key":"pone.0261840.ref035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcvm.2020.00131","article-title":"Covid-19 Kills More Men Than Women: An Overview of Possible Reasons.","volume":"7","author":"A Capuano","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"pone.0261840.ref036","doi-asserted-by":"crossref","first-page":"573925","DOI":"10.3389\/fpubh.2020.573925","article-title":"Demographic and Clinical Characteristics of Early Travel-Associated COVID-19 Cases.","volume":"8","author":"RM Marei","year":"2020","journal-title":"Front Public Health"},{"key":"pone.0261840.ref037","doi-asserted-by":"crossref","first-page":"60","DOI":"10.11606\/s1518-8787.2020054002481","article-title":"A brief-review of the risk factors for COVID-19 severity.","volume":"54","author":"JE Rod","year":"2020","journal-title":"Rev Saude Publica"},{"key":"pone.0261840.ref038","article-title":"Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE).","volume":"75","author":"JPS Peron","year":"2020","journal-title":"Clinics"},{"key":"pone.0261840.ref039","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly","volume":"162","author":"JL Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"pone.0261840.ref040","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort.","author":"M Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"key":"pone.0261840.ref041","doi-asserted-by":"crossref","first-page":"e0237960","DOI":"10.1371\/journal.pone.0237960","article-title":"Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona.","volume":"15","author":"A Sis\u00f3-Almirall","year":"2020","journal-title":"PLoS One"},{"key":"pone.0261840.ref042","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1017\/S0950268821000510","article-title":"Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.","volume":"149","author":"S B\u00f6hm","year":"2021","journal-title":"Epidemiol Infect"},{"key":"pone.0261840.ref043","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0194599820929185","article-title":"Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.","volume":"163","author":"MM Speth","year":"2020","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:49:24Z","timestamp":1640285364000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261840"}},"subtitle":[],"editor":[{"given":"Abdallah M.","family":"Samy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0261840","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}